CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The VADER project trains researchers at the intersection of vaccine design and immune response understanding. By collaborating with industry and academia, it aims to expedite the development of effective vaccines for infectious diseases, particularly targeting impoverished communities.
The successful development of new vaccines depends on the interaction of industrial expertise for vaccine design and engineering with academic understanding of the mechanisms of protection afforded by the immune responses they elicit.
Close interaction between both sectors expedites vaccine development and, in the context of global health, this can translate to the saving of thousands of lives.
The VADER (Vaccine Design and Immune Responses) EID programme, established between the Novartis Vaccin…
THE UNIVERSITY OF BIRMINGHAM
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
GSK VACCINES INSTITUTE FOR GLOBAL HEALTH SRL
Italy, Siena
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
